Natural Hope Herbals' supplement website claims made nine products unapproved new drugs, FDA says.
What happened
In March 2021, FDA reviewed Natural Hope Herbals' website and found it took orders for nine supplement products. FDA said website and newsletter claims showed the products were intended to treat, cure, mitigate, or prevent diseases. FDA also said Prostate Health and Kidney/Bladder were intended for conditions that laypeople cannot safely self-diagnose or treat.
What FDA found
Website and newsletter claims said the supplements would treat, cure, mitigate, or prevent diseases, so FDA treats them as drugs.
Federal Food, Drug, and Cosmetic Act section 201(g)(1)(B) [21 U.S.C. § 321(g)(1)(B)]The products are unapproved new drugs because FDA has not found them generally recognized as safe and effective for those uses.
section 201(p) [21 U.S.C. § 321(p)]; sections 301(d) and 505(a) [21 U.S.C. §§ 331(d) and 355(a)]Prostate Health and Kidney/Bladder lack adequate directions for use because their intended diseases require a licensed practitioner's supervision.
section 502(f)(1) [21 U.S.C. § 352(f)(1)]; 21 CFR 201.5Selling these misbranded drugs in interstate commerce violates the Act.
section 301(a) [21 U.S.C. § 331(a)]
What FDA wants
FDA asks the company to notify it in writing within 15 working days of steps taken to correct the violations, including how it will prevent recurrence and supporting documents. If corrections cannot be completed in that time, the company must explain the delay and give a completion date.
Who should pay attention
- dietary supplement brands that make disease claims
- online herbal and tonic sellers
- companies marketing prostate or urinary products
This is a summary. Read the original letter on fda.gov.